(EMAILWIRE.COM, January 24, 2019 ) The overall body composition analyzer market is poised to reach USD 668.16 million by 2021, growing at a CAGR of 12.7%, during the forecast period of 2016 to 2021. Rise in obese population across the globe, growing health and fitness consciousness among people, increasing government initiatives to encourage physical activity and technological advancements are the key factors driving the growth of this market.

Body composition analysis is the process to evaluate the amount of fat, muscle, and bone in the body. It gives the precise measurement of body fat in relation to lean body mass. Evaluation of body composition is essential in order to determine the risks associated with high or low levels of body fat. A wide range of analyzers are used to assess body composition, at hospitals, fitness centers, academic & research centers, and home.

Sample Report - https://www.marketsandmarkets.com/requestsampleNew.asp?id=248209133

The body composition analyzer market has been segmented, based on product type, into Bio-impedance analyzers, Dual energy X-ray absorptiometry (DEXA), Skinfold calipers, Air displacement plethysmography (ADP), and Hydrostatic weighing. The bio-impedance analyzers segment is expected to command the largest share of the global body composition analyzers market. The large share of the bio-impedance analyzers segment can be attributed to the benefits of these products over other body composition analyzers, such as easy operations, low cost, and better accuracy.

Key Players:
Key players in this market include Tanita Corporation (Japan), Omron Corporation (Japan), InBody Co., Ltd (South Korea), Hologic, Inc. (U.S.) and GE Healthcare (U.S.) among others. These players are increasingly undertaking mergers and acquisitions, and product launches to develop and introduce new technologies and products in the market.